SLNCF — Silence Therapeutics Share News
0.000.00%
- $906.79m
- $714.03m
- £25.38m
- 63
- 11
- 57
- 40
REG - Silence Therapeutics - Silence Therapeutics Report Half-Year 2021 Results
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Total Voting Rights
AnnouncementREG - Silence Therapeutics - Notice of half year results
AnnouncementREG - Silence Therapeutics - Results of Annual General Meeting
AnnouncementREG - Silence Therapeutics - Silence to present SL124 data at EHA
AnnouncementREG - Silence Therapeutics - $40m Payment from AstraZeneca for Collaboration
AnnouncementREG - Silence Therapeutics - Phase 1 Study in Healthy Volunteers Positive Data
AnnouncementREG - Silence Therapeutics - Silence attends RBC Global Healthcare Conference
AnnouncementREG - Silence Therapeutics - Notice of AGM
AnnouncementRCS - Silence Therapeutics - Silence Support International Thalassemia Day
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - First patient dosed in GEMINI II
AnnouncementREG - Silence Therapeutics - Silence Achieves Research Milestone Payment
AnnouncementREG - Silence Therapeutics - Grant of Employee Options
AnnouncementREG - Silence Therapeutics - Purchase of ADS and PDMR Shareholding
AnnouncementREG - Silence Therapeutics - Publication in Cardiovascular Research
Announcement